First Horizon Advisors’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-48
Closed -$7.78K 2316
2024
Q2
$7.78K Sell
48
-1
-2% -$142 ﹤0.01% 1631
2024
Q1
$7.41K Sell
49
-37
-43% -$6.16K ﹤0.01% 1700
2023
Q4
$26.9K Buy
86
+4
+5% +$1.45K ﹤0.01% 1216
2023
Q3
$36.3K Buy
82
+3
+4% +$1.35K ﹤0.01% 995
2023
Q2
$34.2K Buy
79
+17
+27% +$9.55K ﹤0.01% 1051
2023
Q1
$36.9K Buy
62
+18
+41% +$10.1K ﹤0.01% 1023
2022
Q4
$17.8K Sell
44
-22
-33% -$10.3K ﹤0.01% 1297
2022
Q3
$38K Buy
66
+16
+32% +$9.58K ﹤0.01% 940
2022
Q2
$27K Buy
50
+1
+2% +$506 ﹤0.01% 1168
2022
Q1
$31K Buy
49
+43
+717% +$22.2K ﹤0.01% 769
2021
Q4
$3K Buy
+6
New +$3.65K ﹤0.01% 1853

Other funds holding AGL

First Horizon Advisors's AGL Position: Q3 2024 in Review

First Horizon Advisors sold out of Agilon Health (AGL) in Q3 2024, closing a stake of 48 shares — an estimated $7.78K sold.

First Horizon Advisors first reported a position in AGL in Q4 2021 and held it in 11 quarters. The position peaked at $38K in Q3 2022. 209 funds tracked by Wall St. Rank hold AGL as of Q3 2024.

  • First Horizon Advisors reported no remaining Agilon Health position as of Q3 2024 after selling out during the quarter.
  • First Horizon Advisors sold 48 Agilon Health shares in Q3 2024, an estimated $7.78K.
  • First Horizon Advisors first reported a position in Agilon Health in Q4 2021 and held it in 11 quarters.
  • First Horizon Advisors's Agilon Health position peaked at $38K in Q3 2022.
  • 209 funds tracked by Wall St. Rank held Agilon Health as of Q3 2024.

Based on First Horizon Advisors's 13F filing for Q3 2024, filed 8 Nov 2024.